Biosimilars at McKesson

 
spacer
 
Sale Awareness

Biosimlar Perspectives from McKesson Experts

Three Biosimilar Barriers In Community Clinics
McKesson's Omar Hafez and Pete Perron discuss some of their takeaways working with biosimilars in the community clinic space.

From Clinical Use to Reimbursement
Dr. Robert Rifkin, medical director of biosimilars for McKesson, gives an update on biosimilar education and reimbursement.

Perfect Storm for Biosimilar Marketing
Dr. Robert Rifkin discusses the "perfect storm" for biosimilar marketing in a recent OncLive article.

Biosimilars: A Recent Review of Clinical Outcomes
A review of 14,000 individuals transitioned from a reference biologic medication to a biosimilar examines patient safety and treatment efficacy.
 
spacer
spacer
 
Drug Updates

Recent Biosimilar News

 
 
spacer
spacer
 
Helpful Links
  Helpful Links
 
 

McKesson Biosimilar Resource Page

 
Helpful Links
  Contact Us
 
 

Questions? Feel free to contact us at: requests.mshmarketing@mckesson.com

 
spacer
 
© 2018 McKesson Corp. All rights reserved.

Confidentiality Notice: This e-mail message is for the sole use of the intended recipients and may contain confidential and privileged information. Any unauthorized review, use, disclosure or distribution is prohibited.

McKesson Specialty Health, 10101 Woodloch Forest Drive, The Woodlands, TX 77380
msh@mckesson.com www.mckessonspecialtyhealth.com